Healthcare Services Group responds to Genesis bankruptcy filing

Published 10/07/2025, 18:14
Healthcare Services Group responds to Genesis bankruptcy filing

BENSALEM, Pa. - Healthcare Services Group, Inc. (NASDAQ:HCSG), a $1 billion market cap company with strong financial health according to InvestingPro analysis, announced Thursday that it expects to maintain its contractual relationship with Genesis HealthCare facilities despite Genesis filing for Chapter 11 bankruptcy protection on July 9.

HCSG currently provides services to 164 Genesis facilities and anticipates no disruption in service or payments following the bankruptcy filing. The company disclosed that its estimated accounts and notes receivable balances from Genesis, net of reserves, were $50.0 million and $14.4 million respectively as of the petition date. This exposure appears manageable given HCSG’s strong balance sheet, with InvestingPro data showing the company holds more cash than debt and maintains a healthy current ratio of 2.89.

As a result of the Genesis filing, HCSG expects to record a second quarter non-cash charge of approximately $0.62 per share and a third quarter non-cash charge of approximately $0.03 to $0.04 per share.

"We believe the root causes of this action are specific to Genesis and its legacy debt structure," said Ted Wahl, Chief Executive Officer of HCSG, in the press release statement.

Despite this development, HCSG reaffirmed its 2025 expectations of mid-single digit revenue growth and $60.0 to $75.0 million of cash flow from operations, excluding changes in payroll accrual.

The company will release its results for the quarter ended June 30, 2025, on Wednesday, July 23, before market opening, followed by a conference call at 8:30 a.m. Eastern Time.

Healthcare Services Group provides housekeeping, laundry, dining, and nutritional services within the healthcare industry. The company has shown impressive momentum with a 27.8% price return over the past six months, and according to InvestingPro’s Fair Value analysis, the stock currently appears undervalued. Subscribers can access 8 additional ProTips and comprehensive financial analysis in the Pro Research Report.

In other recent news, Healthcare Services Group reported impressive first-quarter 2025 earnings, surpassing expectations with an earnings per share of $0.23, compared to the forecasted $0.18. The company also reported revenue of $447.7 million, exceeding projections of $443.83 million, marking a 5.7% year-over-year growth. This quarter’s performance highlights the company’s strategic focus on organic growth and operational efficiency. Additionally, UBS analyst AJ Rice upgraded Healthcare Services Group’s stock from Neutral to Buy, raising the price target to $15.00, reflecting a positive outlook on the company’s future performance. The analyst anticipates a revenue growth of 5.7% in 2025, surpassing the consensus estimate of 4.8%. Furthermore, the company recently held its annual shareholder meeting, where all nine director nominees were elected, and shareholders approved the compensation of the company’s named executive officers. Grant Thornton LLP was ratified as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2025. These developments indicate strong shareholder support and confidence in the company’s management and strategic direction.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.